Answers are grounded in this paper and cite their sources.
Molecular analyses demonstrate procyanidin A2 improves glucose tolerance in diabetic models, suggesting antioxidant and insulin signaling roles.
Procyanidin A2 (PCA2), a flavonoid from cranberries and lingonberries, has shown various bioactivities, but its antidiabetic effects remain largely under-investigated. This study assessed PCA2's glucose-lowering potential through in silico, in vitro, and in vivo analyses. Molecular docking revealed strong binding of PCA2 to α-glucosidase (PDB: 3TOP), with competitive inhibition (IC₅₀ = 3.62 ± 0.841 µM). PCA2 was non-toxic up to 100 µM in C2C12 and INS-1 cells and enhanced glucose uptake via AMPK/AKT phosphorylation and GLUT4 expression. It also reduced oxidative stress and modulated autophagy-related proteins, increasing Beclin1, LC3-II, and Atg5 while decreasing p62. In diabetic mice, PCA2 improved glucose tolerance, protected β-cells, and restored hepatic and muscular glycogen levels, as confirmed by H&E and PAS staining. Western blotting supported modulation of insulin signaling and autophagy. These findings suggest PCA2 as a promising candidate for functional foods targeting glucose regulation and metabolic dysfunctions.
No takes yet. Share an insight, caveat, or question.
Song et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: